Infusion & Chemotherapy (Mar 2024)

Modern management of leukemoid reactions

  • D.V. Dobrianskyi,
  • G.L. Gumeniuk,
  • P.F. Dudka,
  • I.P. Tarchenko,
  • Т.І. Коzаr,
  • А.V. Кuchаrskа,
  • Т.А. Leonova

DOI
https://doi.org/10.32902/2663-0338-2024-1-44-50
Journal volume & issue
no. 1
pp. 44 – 50

Abstract

Read online

ABSTRACT. Leukemoid reaction (LR) is a transient hematological syndrome of reactive nature characterized by persistent leukocytosis of more than 50,000 cells/µL. LR can be caused by a variety of factors, including infections, intoxications, malignant neoplasms, severe hemorrhages, or acute hemolysis. The most common form of LR is neutrophilic myeloid reaction, which occurs in 80-90 % of cases. The diagnosis of LR is based on clinical examination and laboratory test results, including complete blood count with differential leukocyte formula, determination of leukocyte alkaline phosphatase level, aspiration and biopsy of bone marrow. Differential diagnosis of LR from other forms of leukemia is a challenging task. For this, it is necessary to conduct a thorough examination, including cytogenetic and molecular analysis of peripheral blood and bone marrow granulocytes. Despite certain advances in the differential diagnosis of LR, the mortality rate of patients in the world remains high, which requires the attention of doctors of various profiles. Treatment of LR depends on the underlying cause that caused it. The article proposes a diagnostic and treatment algorithm for LR in the case of its toxico-infectious origin.

Keywords